Cart
sales@molnova.com
Peonidin3-O-(6-O-p-coumaroyl)glucoside
CAS No. 305833-55-0
Peonidin3-O-(6-O-p-coumaroyl)glucoside( ——— )
Catalog No. M39770 CAS No. 305833-55-0
Peonidin3-O-(6-O-p-coumaroyl)glucoside
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePeonidin3-O-(6-O-p-coumaroyl)glucoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionPeonidin3-O-(6-O-p-coumaroyl)glucoside
-
DescriptionPeonidin3-O-(6-O-p-coumaroyl)glucoside
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number305833-55-0
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CL 218872
CL 218872 is a benzodiazepine agonist displaying selectivity for α1 subunit-containing GABAA receptors (Ki values are 130, 1820, 1530, > 10000, 490 and > 10000 nM for α1, α2, α3, α4, α5 and α6-subunit containing receptors respectively).
-
Momordicoside X
Momordicoside X displays moderate insulin secretion activity.
-
Lupartumab
Lupartumab (BAY 1112623) is a monoclonal antibody targeting LYPD3 (C4.4A) and is employed in the synthesis of antibody-active molecular couplers for studying LYPD3-associated tumor diseases.
